The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Digitalization has reached the Pharmaceutical Industry. The ability to leverage the potential of data to master processes and products as differentiator has been understood. The transformation from a classical documentation-based, functionally segregated towards a data-driven, end-to-end integrated production and quality management is one major objective towards the Pharma 4.0. The Holistic Control Strategy and Digital SOPs are enabler and accelerator for Pharma 4.0. The panel/roundtable session will be introduced by two presentations addressing the ISPE Pharma 4.0 Holistic Control Strategy Model and the concept of the SOP of the Future – the right information at the right time and what the world might look like under the assumption of full digital implementation. This session will include a short mock-up demo in which digital SOPs are seamlessly integrated into the shop floor execution. The interactive Panel Discussion will be initiated by the following questions: • What kind of initiatives do you run to improve/transform your product supply and/or SOP Management towards digitalization? • What are the benefits you are expecting? • What are the challenges and risks?
Session Leader(s):
Heike
Roeder,
Lead Digital Transformation QMS,
Bayer AG